Prescription drug · ANDA
Prednisone NDC 63187-807
Prednisone 20 mg/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63187-807-05 | 63187080705 | 5 TABLET in 1 BOTTLE (63187-807-05)Marketed from Feb 1, 2017 | |
| 63187-807-06 | 63187080706 | 6 TABLET in 1 BOTTLE (63187-807-06)Marketed from Feb 1, 2017 | |
| 63187-807-07 | 63187080707 | 7 TABLET in 1 BOTTLE (63187-807-07)Marketed from Apr 3, 2017 | |
| 63187-807-08 | 63187080708 | 8 TABLET in 1 BOTTLE (63187-807-08)Marketed from Feb 1, 2017 | |
| 63187-807-09 | 63187080709 | 9 TABLET in 1 BOTTLE (63187-807-09)Marketed from Feb 1, 2017 | |
| 63187-807-10 | 63187080710 | 10 TABLET in 1 BOTTLE (63187-807-10)Marketed from Feb 1, 2017 | |
| 63187-807-12 | 63187080712 | 12 TABLET in 1 BOTTLE (63187-807-12)Marketed from Feb 1, 2017 | |
| 63187-807-14 | 63187080714 | 14 TABLET in 1 BOTTLE (63187-807-14)Marketed from Nov 1, 2018 | |
| 63187-807-15 | 63187080715 | 15 TABLET in 1 BOTTLE (63187-807-15)Marketed from Feb 1, 2017 | |
| 63187-807-18 | 63187080718 | 18 TABLET in 1 BOTTLE (63187-807-18)Marketed from Mar 1, 2018 | |
| 63187-807-20 | 63187080720 | 20 TABLET in 1 BOTTLE (63187-807-20)Marketed from Feb 1, 2017 | |
| 63187-807-21 | 63187080721 | 21 TABLET in 1 BOTTLE (63187-807-21)Marketed from Feb 1, 2017 | |
| 63187-807-24 | 63187080724 | 24 TABLET in 1 BOTTLE (63187-807-24)Marketed from Feb 1, 2017 | |
| 63187-807-30 | 63187080730 | 30 TABLET in 1 BOTTLE (63187-807-30)Marketed from Feb 1, 2017 | |
| 63187-807-40 | 63187080740 | 40 TABLET in 1 BOTTLE (63187-807-40)Marketed from Feb 1, 2017 | |
| 63187-807-42 | 63187080742 | 42 TABLET in 1 BOTTLE (63187-807-42)Marketed from Feb 1, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Prednisone
- Generic name (nonproprietary)
- prednisone
- Active ingredients
- Prednisone — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040362
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 63187-807_69508b79-c086-493a-a46f-b9ab7c60a519SPL ID 69508b79-c086-493a-a46f-b9ab7c60a519SPL set ID e4555299-af68-416f-8999-9bb703a45e77RxCUI 312615UNII VB0R961HZT
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463187080705followed by a unit qualifier and the quantityPackage 63187-0807-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS Prednisone Tablets, USP are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) Congenital adrenal hyperplasia Nonsuppurative thyroiditis 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040362
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Prednisone | Prednisone 10 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 66267-812 |
| Prednisone | Prednisone 20 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 66267-860 |
| Prednisone | Prednisone 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-3137 |
| Prednisone | Prednisone 10 mg/1 | TabletOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0193 |
| Prednisone | Prednisone 20 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3143 |
| Prednisone | Prednisone 10 mg/1 | TabletOral | Proficient Rx LP | 63187-300 |
| Prednisone | Prednisone 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-3354 |
| Prednisone | Prednisone 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-7124 |
| Prednisone | Prednisone 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-3361 |
| Prednisone | Prednisone 5 mg/1 | TabletOral | Proficient Rx LP | 63187-020 |
| Prednisone | Prednisone 5 mg/1 | TabletOral | Asclemed USA, Inc. | 76420-067 |
| Prednisone | Prednisone 10 mg/1 | TabletOral | Asclemed USA, Inc. | 76420-068 |
| Prednisone | Prednisone 5 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0069 |
| Prednisone | Prednisone 20 mg/1 | TabletOral | Asclemed USA, Inc. | 76420-069 |
| Prednisone | Prednisone 20 mg/1 | TabletOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0105 |
| Prednisone | Prednisone 5 mg/1 | TabletOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0106 |
| Prednisone | Prednisone 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-5202 |
| Prednisone | Prednisone 10 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 66267-171 |
| Prednisone | Prednisone 5 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 66267-172 |